A study from the Texas A&M University School of Public Health sheds new light on the relationship between community cohesion prior to a natural disaster and resilience after one, with possible policy applications for public health and emergency preparedness practitioners.

Living with cardiovascular disease often takes a serious emotional toll - and with stress known to worsen heart health, there’s growing interest in low-risk, innovative ways to help patients cope. New research from UCLA Health suggests that virtual reality (VR) may offer a promising tool to ease psychological stress and support heart health. 

Researchers at The University of Texas at Arlington are launching a two-year study to explore whether data from everyday fitness trackers can help predict a person’s risk of developing cardiovascular disease. Backed by a $400,000 grant from the Texas Higher Education Coordinating Board, the study officially started on Aug. 1 and will use commercially available wearable devices to monitor physical activity, sleep and blood pressure.

Despite concerns about increased stimulant prescribing, nonmedical use of ADHD drugs among adolescents has declined in the last 20 years, a University of Michigan study shows.

While medical use of prescription stimulants for ADHD among adolescents increased slightly between 2005 and 2023, nonmedical use declined more.

"Lifetime medical use was 2% lower in 2005 when compared to nonmedical use, and is now 2% higher," said study co-author Philip Veliz, U-M research associate professor at the U-M School of Nursing and Center for the Study of Drugs, Alcohol, Smoking, and Health

Dr. Adekemi Adeniyan, Executive Director of the Dentalcare Foundation, rural dentist, and advocate for oral health advancement in Nigeria, has been named the Institute for Health Metrics and Evaluation’s (IHME) 2025 Roux Prize winner. The prize embodies the mission of the Global Burden of Disease Study (GBD), led by IHME, the most extensive and thorough scientific effort ever to quantify health levels and trends worldwide. 

New research published today in Nature from Ryan Flynn, MD, PhD, in collaboration with Vijay Rathinam, DVM, PhD, and his graduate student Vincent Graziano at UConn Health and other colleagues at Boston Children’s Hospital and UConn Health has uncovered powerful evidence that may explain why a new chemical modification of RNA is made in cells. The findings could provide new concepts for understanding the development of autoimmunity and how bacterial pathogens are detected — and ultimately help identify new therapeutic targets.

The technique, which used genetically healthy donor cells, prolonged life and function in mice with a disease similar to Tay-Sachs. It may help with other neurodegenerative diseases like Alzheimer’s.